Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Hoth Therapeutics, Inc. (HOTH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-K10-K
Revenues   [+]65.30.00.02.90.5
            Revenue growth  -156195.3%3452.1%-100.0%475.5% 
Cost of goods sold  2.6-3.0-1.52.90.5
Gross profit  62.73.01.50.00.0
            Gross margin  96.0%-7161.8%-123475.0%0.0%0.0%
Selling, general and administrative   [+]3.53.52.52.10.7
Research and development  4.87.42.32.00.8
Equity in earnings  -0.4    
Other operating expenses  65.36.24.03.61.0
EBITDA   [+]  -7.3-7.7-2.5
            EBITDA margin  -17.5%33729.0%620300.0%-263.0%-489.4%
Depreciation and amortization    0.00.00.0
EBIT   [+]-11.4-14.1-7.3-7.7-2.5
            EBIT margin  -17.5%33729.0%620388.6%-263.0%-489.6%
Interest income  0.0    
Other income (expense), net   [+]0.1-0.20.10.0 
Pre-tax income  -11.4-14.3-7.2-7.7-2.5
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -11.4-14.3-7.2-7.7-2.5
            Net margin  -17.4%34158.0%611539.2%-262.7%-489.6%
   
Basic EPS   [+]($9.50)($15.99)($0.58)($0.84)($0.50)
Diluted EPS   [+]($9.50)($15.99)($0.58)($0.84)($0.50)
   
Shares outstanding (basic)   [+]1.20.912.49.25.0
Shares outstanding (diluted)   [+]1.20.912.49.25.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy